BACKGROUND: Little is known about disability in early-stage chronic kidney disease (CKD). STUDY DESIGN: Cross-sectional national survey (National Health and Nutrition Examination Survey 1999-2006). SETTING & PARTICIPANTS: Community-based survey of 16,011 noninstitutionalized US civilian adults (aged ≥20 years). PREDICTOR: CKD, categorized as no CKD, stages 1 and 2 (albuminuria and estimated glomerular filtration rate [eGFR] ≥60 mL/min/1.73 m²), and stages 3 and 4 (eGFR, 15-59 mL/min/1.73 m²). OUTCOME: Self-reported disability, defined by limitations in working, walking, and cognition and difficulties in activities of daily living (ADL), instrumental ADL, leisure and social activities, lower-extremity mobility, and general physical activity. MEASUREMENTS: Albuminuria and eGFR assessed from urine and blood samples; disability, demographics, access to care, and comorbid conditions assessed using a standardized questionnaire. RESULTS: Age-adjusted prevalence of reported limitations generally was significantly greater with CKD: for example, difficulty with ADL was reported by 17.6%, 24.7%, and 23.9% of older (≥65 years) and 6.8%, 11.9%, and 11.0% of younger (20-64 years) adults with no CKD, stages 1 and 2, and stages 3 and 4, respectively. CKD also was associated with greater reported limitations and difficulty in other activities after age adjustment, including instrumental ADL, leisure and social activities, lower-extremity mobility, and general physical activity. Other demographics, socioeconomic status, and access to care generally only slightly attenuated the observed associations, particularly in older individuals; adjustment for cardiovascular disease, arthritis, and cancer attenuated most associations such that statistical significance no longer was achieved. LIMITATIONS: Inability to establish causality and possible unmeasured confounding. CONCLUSION: CKD is associated with a higher prevalence of disability in the United States. Age and other comorbid conditions account for most, but not all, of this association. Copyright Â
BACKGROUND: Little is known about disability in early-stage chronic kidney disease (CKD). STUDY DESIGN: Cross-sectional national survey (National Health and Nutrition Examination Survey 1999-2006). SETTING & PARTICIPANTS: Community-based survey of 16,011 noninstitutionalized US civilian adults (aged ≥20 years). PREDICTOR: CKD, categorized as no CKD, stages 1 and 2 (albuminuria and estimated glomerular filtration rate [eGFR] ≥60 mL/min/1.73 m²), and stages 3 and 4 (eGFR, 15-59 mL/min/1.73 m²). OUTCOME: Self-reported disability, defined by limitations in working, walking, and cognition and difficulties in activities of daily living (ADL), instrumental ADL, leisure and social activities, lower-extremity mobility, and general physical activity. MEASUREMENTS: Albuminuria and eGFR assessed from urine and blood samples; disability, demographics, access to care, and comorbid conditions assessed using a standardized questionnaire. RESULTS: Age-adjusted prevalence of reported limitations generally was significantly greater with CKD: for example, difficulty with ADL was reported by 17.6%, 24.7%, and 23.9% of older (≥65 years) and 6.8%, 11.9%, and 11.0% of younger (20-64 years) adults with no CKD, stages 1 and 2, and stages 3 and 4, respectively. CKD also was associated with greater reported limitations and difficulty in other activities after age adjustment, including instrumental ADL, leisure and social activities, lower-extremity mobility, and general physical activity. Other demographics, socioeconomic status, and access to care generally only slightly attenuated the observed associations, particularly in older individuals; adjustment for cardiovascular disease, arthritis, and cancer attenuated most associations such that statistical significance no longer was achieved. LIMITATIONS: Inability to establish causality and possible unmeasured confounding. CONCLUSION: CKD is associated with a higher prevalence of disability in the United States. Age and other comorbid conditions account for most, but not all, of this association. Copyright Â
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Jane Marsh; Lesley A Stevens; John W Kusek; Frederick Van Lente Journal: Clin Chem Date: 2007-03-01 Impact factor: 8.327
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Michael G Shlipak; Catherine Stehman-Breen; Linda F Fried; Xiao Song; David Siscovick; Linda P Fried; Bruce M Psaty; Anne B Newman Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860
Authors: Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh Journal: Am J Kidney Dis Date: 2007-12 Impact factor: 8.860
Authors: Janet L Welch; Michelle Johnson; Lani Zimmerman; Cynthia L Russell; Susan M Perkins; Brian S Decker Journal: West J Nurs Res Date: 2014-09-18 Impact factor: 1.967
Authors: Peter P Reese; Anne R Cappola; Justine Shults; Raymond R Townsend; Crystal A Gadegbeku; Cheryl Anderson; Joshua F Baker; Dean Carlow; Michael J Sulik; Joan C Lo; Alan S Go; Bonnie Ky; Laura Mariani; Harold I Feldman; Mary B Leonard Journal: Am J Nephrol Date: 2013-10-04 Impact factor: 3.754